Fact CheckerSign in

NCT01890486Recruiting

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

The Prospective Collection, Storage and Reporting of Data on Patients

Source: ClinicalTrials.gov · Last updated 13 Apr 2026

Brief summary (registry, in English)

To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.

Status (registry)
Recruiting
Study type
Observational
Enrollment
2000 (estimated)
First submitted
27 Jun 2013
Start date
21 May 2001
Primary completion date
31 Dec 2026
Lead sponsor
Wake Forest University Health Sciences
NCT number
NCT01890486

What you commit to

  • Study type: Observational
  • Planned participants: 2000
  • From 21 May 2001 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Participation in any other treatment research protocol

Who the study is looking for

  • Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant

Age in the registry: 18 years to 120 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Wake Forest Baptist Health
Coordinator of this site? Confirm its status
Winston-SalemUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.